Promega Corporation Enters License Agreement with Broad Institute to Access CRISPR-Cas9 Gene Editing Technology

Promega Corporation announced today it has signed a non-exclusive license agreement with the Broad Institute of MIT and Harvard to sell tools and reagents for CRISPR-Cas9 gene editing, providing scientists new tools for interrogating endogenous biology. Under the agreement, Promega will combine CRISPR-Cas9 technology with its products that knock-in Promega genetic reporters to the genomes of... Read more

Adent completes transition as Neogen’s CEO

LANSING, Mich., Jan. 29, 2019 — Neogen Corporation (NASDAQ: NEOG) announced today that its transition of the responsibilities from James Herbert to John Adent as the company’s chief executive officer is now complete. Herbert will continue to serve as chairman of Neogen’s Board of Directors, and as the company’s director of strategic growth under the... Read more

Abcam expands custom services capabilities with the acquisition of Calico Biolabs

London and Cambridge, UK, 28 January 2019: Abcam plc, a global innovator in life science reagents and tools, is pleased to announce its acquisition of Calico Biolabs, a developer of custom high-quality recombinant rabbit monoclonal antibodies for diagnostics and pharmaceutical company partners. Joyce Young, Vice President of Custom Services, Abcam commented:“This acquisition strategically expands our leadership... Read more

Boards of E. Merck KG, Darmstadt, Germany, Newly Elected

Darmstadt, Germany, January 28, 2019 – At the Partners’ Meeting of E. Merck KG, Darmstadt, Germany (EM), last weekend the Merck family partners elected their representatives to the Family Board and Board of Partners in a regularly scheduled election held every five years. The incumbent chairmen of these two boards were re-elected: Dr. Frank Stangenberg-Haverkamp (70), Chairman... Read more

Bio-Techne Introduces CE-SDS PLUS for Maurice™ System

Minneapolis, January 28, 2019/PRNewswire/ — Bio-Techne today announced the launch of the CE-SDS PLUS system for its ProteinSimple-branded Maurice™ platform. This new system further expands the usability of Maurice’s proprietary cartridge and reduces undesirable protein fragmentation during separation. Since its introduction in 2016, Maurice has enabled capillary electrophoresis – sodium dodecyl sulfate (CE-SDS) for size-based... Read more

HORIBA Instruments Acquires All Shares of MANTA Instruments

28 January 2019 Augmenting the Technology of Particle Characterization Instruments HORIBA, Ltd. (Head Office: Kyoto, Japan; hereinafter, “HORIBA”) has announced that HORIBA Instruments Incorporated (Head Office: Irvine, USA; hereinafter, “HORIBA Instruments”) acquired all shares of MANTA Instruments, Inc. (Head Office: San Diego, USA; hereinafter, “MANTA”) on January 24, 2019. MANTA has earned a high reputation... Read more

1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution

Powerful Single Cell Bioinformatics Solution in a Graphical User Interface Powerful Single Cell Bioinformatics Solution in a Graphical User Interface ST. LOUIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize... Read more

Belec announces NEW DISTRIBUTOR

01/24/2019 for Vietnam, Cambodia, Myanmar and Laos We are pleased that we can announce to have a new dealer for Vietnam since today. A young but experienced and motivated team of engineers from BKB Scientific in Ho Chi Minh City complements our worldwide network of distribution partners. The two managing directors, Mr. Le Nguyen Yen... Read more

BIO-TECHNE LAUNCHES CELL AND GENE THERAPY PORTFOLIO

MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ — Bio-Techne announces the launch of their cell and gene therapy portfolio. As a leading manufacturer of GMP-grade ancillary materials and automated instrumentation, Bio-Techne is uniquely able to offer solutions that advance the translation of cell and gene therapies, from discovery-level research to the optimization of cell therapy manufacturing unit... Read more